• TERT (Telomerase Reverse Transcriptase) Gene Mutation Analysis
  • Dopamine Receptor D4 (DRD4) Genotyping
  • Antithrombin III
  • Giardia Species by PCR, Stool
  • Interleukin 6 (IL-6), Serum
  • Levorphanol, Urine
  • Antinuclear Antibody (ANA), IFA Patterning
  • Cortisol, Free, Random, Urine
  • Chromosome Analysis, Solid Tumors
  • Alpha-galactosidase A (GLA) Mutation Analysis
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /BCR-ABL1 Mutation Analysis for Tyrosine Kinase Inhibitor Resistance
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

BCR-ABL1 Mutation Analysis for Tyrosine Kinase Inhibitor Resistance
Medical Test

Diseases (5)
Access to BCR-ABL1 Mutation Analysis for Tyrosine Kinase Inhibitor Resistance is restricted.
Loading...